Evidence map›Paper›PMID 42452957›Full record

ArticleEuropean journal of neurology2026

Diagnostic Value of Spinal Cord Lesion Metabolism on [

Antoine Gavoille, Anthime Flaus, Matthieu Dietz, Julie Pique, Antoine Seyve, Pierre Lardeux, Romain Marignier, Marc Janier, Pascal Sève

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Antoine GavoilleService de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-inflammation, Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle (MIRCEM), Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.ORCID https://orcid.org/0000-0002-9118-0849
Anthime FlausDépartement de médecine nucléaire, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.ORCID https://orcid.org/0000-0001-5877-2159
Matthieu DietzImagerie Nucléaire de l'Ouest Lyonnais et de l'ain, Clinique de la Sauvegarde, Ramsay Santé, Lyon, France.
Julie PiqueService de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-inflammation, Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle (MIRCEM), Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Antoine SeyveService de Neuro-oncologie, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Pierre LardeuxService de Neuro-cognition et Neuro-Ophtalmologie, Hospices Civils de Lyon, Lyon, France.
Romain MarignierService de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-inflammation, Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle (MIRCEM), Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Marc JanierDépartement de médecine nucléaire, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
Pascal SèveService de Médecine Interne, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction[

methodsWe conducted a retrospective cohort study of patients presenting with spinal cord lesions who underwent [

resultsA total of 106 patients were included: 60 (56.6%) with inflammatory myelitis, 20 (18.9%) with neurosarcoidosis, 10 (9.4%) with tumoral lesions, and 16 (15.1%) with other etiologies. Hypermetabolism was found in 80.0% of tumoral lesions, 50.0% of neurosarcoidosis, and 23.3% of inflammatory myelitis. PET/CT showed good performance in differentiating inflammatory myelitis or neurosarcoidosis from tumoral lesions using qualitative analysis (hypermetabolism: sensitivity 0.77, specificity 0.80, and 0.50, respectively) and quantitative analysis (SUV

conclusionSpinal cord hypermetabolism on [

Indexed as

Central Nervous System DiseasesMyelitisPositron Emission Tomography Computed TomographySarcoidosisSpinal CordSpinal Cord DiseasesSpinal Cord NeoplasmsAdultAgedDiagnosis, DifferentialFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals[18F]FDG PET/CTmyelitismyelopathyneurosarcoidosisspinal cord tumor

Identifiers

PMID42452957
PMCPMC13370103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.